Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on: May 26,2024 8

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on:May 26,2024 8

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024 5

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024 5

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on: December 28,2023 13

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on:December 28,2023 13

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on: December 02,2024 0

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on:December 02,2024 0

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024 12

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024 12

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on: December 22,2023 6

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on:December 22,2023 6

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on: January 25,2024 24

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on:January 25,2024 24

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on: January 26,2024 25

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on:January 26,2024 25

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024 9

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024 9

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Updated on: April 23,2024 19

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Updated on:April 23,2024 19

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024 0

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024 0

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024 9

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024 9